Cited by 597Steroid Chemistry and BiochemistryMicrobial Natural Products and BiosynthesisMicrobial Metabolic Engineering and Bioproduction

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

Open access
Funabashi, Masanori, Grove, Tyler L., Wang, Min, Varma, Yug, McFadden, Molly E., Brown, Laura C., Guo, Chunjun, Higginbottom, Steven +2 more·2020·Nature

Published version of a preprint

Abstract

The gut microbiota synthesize hundreds of molecules, many of which influence host physiology. Among the most abundant metabolites are the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), which accumulate at concentrations of around 500 μM and are known to block the growth of Clostridium difficile 1, promote hepatocellular carcinoma 2 and modulate host metabolism via the G-protein-coupled receptor TGR5 (ref. 3). More broadly, DCA, LCA and their derivatives are major components of the recirculating pool of bile acids 4; the size and composition of this pool are a target of therapies for primary biliary cholangitis and nonalcoholic steatohepatitis. Nonetheless, despite the clear impact of DCA and LCA on host physiology, an incomplete knowledge of their biosynthetic genes and a lack of genetic tools to enable modification of their native microbial producers limit our ability to modulate secondary bile acid levels in the host. Here we complete the pathway to DCA and LCA by assigning and characterizing enzymes for each of the steps in its reductive arm, revealing a strategy in which the A-B rings of the steroid core are transiently converted into an electron acceptor for two reductive steps carried out by Fe-S flavoenzymes. Using anaerobic in vitro reconstitution, we establish that a set of six enzymes is necessary and sufficient for the eight-step conversion of cholic acid to DCA. We then engineer the pathway into Clostridium sporogenes, conferring production of DCA and LCA on a nonproducing commensal and demonstrating that a microbiome-derived pathway can be expressed and controlled heterologously. These data establish a complete pathway to two central components of the bile acid pool.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2396-4

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bacteria in the gastrointestinal tract produce amino acid bile acid amidates that can affect host-mediated metabolic processes.

    “Bacteria in the gastrointestinal tract produce amino acid bile acid amidates that can affect host-mediated metabolic processes1–6; however, the bacterial gene(s) responsible for their production remain unknown.”

    From Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase (2022) · cites this paper as [5]

    The Abstract says gut bacteria produce the secondary bile acids DCA and LCA, which modulate host metabolism. It does not say they produce amino acid bile acid amidates or that those amidates affect host metabolic processes; the paper addresses a different class of bile acid products. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Funabashi, M., Grove, T. L., Wang, M., Varma, Y., McFadden, M. E., Brown, L. C., Guo, C., Higginbottom, S., Almo, S. C., & Fischbach, M. A.
Affiliations
  • Daiichi Sankyo RD Novare (Japan) (JP)
  • Albert Einstein College of Medicine (US)
  • Stanford University (US)
  • Indiana University Bloomington (US)
  • Stanford Medicine (US)
  • Chan Zuckerberg Biohub San Francisco (US)
Corresponding author
  • Almo, Steven C.
  • Fischbach, Michael A.
Venue
Nature
Published
2020-06-17
Volume
582
Issue
7813
Pages
566-570
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3036012425
Cited by
590
References
46
Citations by year
2026: 125 · 2025: 108 · 2024: 123 · 2023: 89 · 2022: 78 · 2021: 53 · 2020: 13
FWCI
18.90
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Price Family Foundation
  • National Institutes of Health (1dp2hd101401-01, GM093342, DK113598, DK110174, GM094662)
  • National Heart, Lung, and Blood Institute (P01HL147823)
  • National Institute of General Medical Sciences (U54GM093342, U54GM094662, P01GM118303)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK110174, DP1DK113598, R01DK101674)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (DP2 HD101401)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Steroid Chemistry and Biochemistry
  • Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
Keywords
secondary bile acids, deoxycholic acid, lithocholic acid, gut microbiota, reductive dehydroxylation, cholic acid, Clostridium sporogenes, heterologous pathway expression, germ-free mice, primary biliary cirrhosis, nonalcoholic steatohepatitis, TGR5
MeSH terms
Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Clostridium, Deoxycholic Acid, Hydroxylation, Lithocholic Acid, Male, Operon, Symbiosis, Mice, Metabolic Networks and Pathways, Metabolic Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review